by Oleg Vishnevski | Jan 21, 2021 | Products |
Early postnatal hypoferremia in low birthweight and preterm babies: A prospective cohort study in hospital-delivered Gambian neonates Abstract Background Neonates, particularly those born preterm (PTB) and with low birthweight (LBW), are especially susceptible...
by Oleg Vishnevski | Jan 19, 2021 | Products |
Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture-negative Highlights In contrast to HIV-related tuberculosis, evaluations of the influence of hepcidin in non-HIV-related...
by Oleg Vishnevski | Jan 12, 2021 | Products |
Hepcidin 25 HS & HIV Antiretroviral Therapy Study High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy. Abstract Purpose: This...
by Oleg Vishnevski | Sep 30, 2020 | News, Products |
Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis Context: Severe energy deprivation markedly inhibits erythropoiesis by restricting iron availability for hemoglobin synthesis. Objective:...
by Oleg Vishnevski | Sep 24, 2020 | News, Products |
Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children See full study: https://iopscience.iop.org/article/10.1088/1742-6596/1246/1/012023/meta Abstract Chronic kidney disease (CKD) may present with anemia of chronic disease (ACD),...
